Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1400118	重组抗TNFα全人源单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2015-03-24	上海迈泰亚博生物技术有限公司	Shanghai MabLab Biotechnology Co Ltd	Certificate Issued	2016-09-03	view
CXSL1700098	重组抗TNFα全人源单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2017-11-01	安徽未名达木生物医药有限公司	Anhui Weiming Damu Biomedical Co Ltd	Certificate Issued	2018-09-03	view
CXSL1500038	重组抗TNFα全人源单克隆抗体注射液	adalimumab	Injection	Biological Products(2)	New Drug Application	2015-07-29	泰州迈博太科药业有限公司	Taizhou Maibotaike Pharmaceutical Co Ltd	Certificate Issued	2016-06-27	view